Last 12 months
Inside the activity.
18 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 4 | 0 |
| Jan 2026 | 0 | 9 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 13 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 09, 2025 Filed Feb 23, 2026 21:05 UTC Amendment |
Stuka PaulDirector
|
PurchaseCommon Stock | 2,710 | $1.81 | $4,905.10 |
DisclosureSEC source: 0001493152-26-007752 · ownership.xml · nonDerivative · entry 1 Stuka Paul · CIK 0001528577 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 391,628 F1 · shares: This Form 4/A amends the Form 4 filed on December 11, 2025 solely to correct the number of shares reported in Table I, Column 4. The number of shares reported in Column 5 was correct as originally filed. No other changes have been made. F2 · price: The price reported is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $1.80 to $1.81. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range. Read SEC document |
| December 05, 2025 Filed Dec 8, 2025 21:05 UTC |
Stuka PaulDirector
|
PurchaseCommon Stock | 5,073 | $1.86 | $9,435.78 |
DisclosureSEC source: 0001493152-25-026629 · ownership.xml · nonDerivative · entry 1 Stuka Paul · CIK 0001528577 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 388,918 Read SEC document |
| December 04, 2025 Filed Dec 5, 2025 21:05 UTC |
Stuka PaulDirector
|
PurchaseCommon Stock | 10,130 | $1.85 | $18,740.50 |
DisclosureSEC source: 0001493152-25-026356 · ownership.xml · nonDerivative · entry 1 Stuka Paul · CIK 0001528577 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 383,845 Read SEC document |
| November 12, 2025 Filed Nov 13, 2025 21:05 UTC |
Stuka PaulDirector
|
PurchaseCommon Stock | 13,431 | $1.62 | $21,758.22 |
DisclosureSEC source: 0001493152-25-022284 · ownership.xml · nonDerivative · entry 1 Stuka Paul · CIK 0001528577 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 373,715 Read SEC document |
| October 07, 2025 Filed Oct 9, 2025 20:05 UTC |
ROUBIN GARY SDirector
|
GrantCommon Stock | 48,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-017587 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 656,425 F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on October 7, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 20:20 UTC |
Kester Thomas JDirector
|
GrantOptions to purchase common stock (right to buy) · Derivative | 19,041 | $0.00 Strike: $2.38 | $0.00 |
DisclosureSEC source: 0001493152-25-013888 · ownership.xml · derivative · entry 2 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,041 Underlying: Common Stock · 19,041 shares Expires 2027-09-15 Read SEC document |
| September 15, 2025 Filed Sep 17, 2025 20:20 UTC |
Kester Thomas JDirector
|
GrantCommon Stock | 37,815 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-013888 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 458,573 F1 · shares: Represent grant of shares of common stock for services rendered as a director of the issuer in 2025 prior to the Reporting Person's resignation as a director, effective September 16, 2025. Read SEC document |
| July 30, 2025 Filed Aug 1, 2025 21:00 UTC |
ROUBIN GARY SDirector
|
PurchaseCommon Stock | 41,322 | $2.42 | $99,999.24 |
DisclosureSEC source: 0001641172-25-021934 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 608,425 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 30, 2025 pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement"). F2 · price: The purchase price per share of common stock in the Private Placement was $2.42. Read SEC document |
| July 30, 2025 Filed Aug 1, 2025 21:00 UTC |
Slosman MarvinDirector · CEO and President
|
PurchaseCommon Stock | 10,330 | $2.42 | $24,998.60 |
DisclosureSEC source: 0001641172-25-021931 · ownership.xml · nonDerivative · entry 1 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,420,866 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 30, 2025 pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement"). F2 · price: The purchase price per share of common stock in the Private Placement was $2.42. Read SEC document |
| July 30, 2025 Filed Aug 1, 2025 21:00 UTC |
Kester Thomas JDirector
|
PurchaseCommon Stock | 30,991 | $2.42 | $74,998.22 |
DisclosureSEC source: 0001641172-25-021933 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420,758 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 30, 2025 pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement"). F2 · price: The purchase price per share of common stock in the Private Placement was $2.42. Read SEC document |
| July 30, 2025 Filed Aug 1, 2025 21:00 UTC |
Stuka PaulDirector
|
PurchaseCommon Stock | 20,661 | $2.42 | $49,999.62 |
DisclosureSEC source: 0001641172-25-021930 · ownership.xml · nonDerivative · entry 1 Stuka Paul · CIK 0001528577 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 444,195 F1 · shares: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 30, 2025 pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement"). F2 · price: The purchase price per share of common stock in the Private Placement was $2.42. F3 · ownership.direct: These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. Read SEC document |
| July 11, 2025 Filed Jul 23, 2025 20:05 UTC |
Kester Thomas JDirector
|
OtherSeries I Warrant (right to buy) · Derivative | 30,624 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001641172-25-020694 · ownership.xml · derivative · entry 2 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,624 shares Expires 2025-07-23 Read SEC document |
| July 11, 2025 Filed Jul 23, 2025 20:05 UTC |
Kester Thomas JDirector
|
OtherCommon Stock | 30,624 | $1.38 | $42,343.80 |
DisclosureSEC source: 0001641172-25-020694 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 389,767 Read SEC document |
| July 01, 2025 Filed Jul 23, 2025 20:05 UTC |
Stuka PaulDirector
|
OtherSeries I Warrant (right to buy) · Derivative | 87,500 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001641172-25-020693 · ownership.xml · derivative · entry 3 Stuka Paul · CIK 0001528577 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 87,500 shares Expires 2025-07-23 F1 · ownership.direct: These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. Read SEC document |
| July 01, 2025 Filed Jul 23, 2025 20:05 UTC |
Stuka PaulDirector
|
OtherCommon Stock | 87,500 | $1.38 | $120,986.25 |
DisclosureSEC source: 0001641172-25-020693 · ownership.xml · nonDerivative · entry 1 Stuka Paul · CIK 0001528577 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 423,534 F1 · ownership.direct: These securities are held by Osiris Investment Partners, L.P. ("Osiris"). The Reporting Person serves as the managing member of Osiris Partners, LLC, the general partner of Osiris. In such capacity, the Reporting Person may be deemed to beneficially own the reported securities. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein, and the inclusion of such securities in this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. Read SEC document |
| June 29, 2025 Filed Jul 23, 2025 20:05 UTC |
BERMAN MICHAELDirector
|
OtherSeries I Warrant (right to buy) · Derivative | 61,248 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001641172-25-020695 · ownership.xml · derivative · entry 3 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 0 Underlying: Common Stock · 61,248 shares Expires 2025-07-23 F1 · ownership.nature: These securities are held by the Michael Berman Revocable Trust. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. Read SEC document |
| June 29, 2025 Filed Jul 23, 2025 20:05 UTC |
BERMAN MICHAELDirector
|
OtherCommon Stock | 61,248 | $1.38 | $84,687.61 |
DisclosureSEC source: 0001641172-25-020695 · ownership.xml · nonDerivative · entry 1 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See Footnote Disclosed balance after: 244,994 F1 · ownership.nature: These securities are held by the Michael Berman Revocable Trust. No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only. Read SEC document |
| June 25, 2025 Filed Jul 23, 2025 20:05 UTC |
ROUBIN GARY SDirector
|
OtherSeries I Warrant (right to buy) · Derivative | 30,624 | $0.00 Strike: $1.38 | $0.00 |
DisclosureSEC source: 0001641172-25-020692 · ownership.xml · derivative · entry 2 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,624 shares Expires 2025-07-23 Read SEC document |
| June 25, 2025 Filed Jul 23, 2025 20:05 UTC |
ROUBIN GARY SDirector
|
OtherCommon Stock | 30,624 | $1.38 | $42,343.80 |
DisclosureSEC source: 0001641172-25-020692 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 567,103 Read SEC document |
| May 30, 2025 Filed May 21, 2026 21:16 UTC |
Gleason Shane ThomasChief Commercial Officer
|
SaleCommon Stock | 7,186 | $2.51 | $18,036.86 |
DisclosureSEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 12 Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,079,601 F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person. Read SEC document |
| May 29, 2025 Filed May 21, 2026 21:16 UTC |
Gleason Shane ThomasChief Commercial Officer
|
SaleCommon Stock | 3,760 | $2.51 | $9,437.60 |
DisclosureSEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 11 Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,086,787 F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person. Read SEC document |
| May 27, 2025 Filed May 21, 2026 21:16 UTC |
Gleason Shane ThomasChief Commercial Officer
|
SaleCommon Stock | 1,572 | $2.51 | $3,945.72 |
DisclosureSEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 10 Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,090,547 F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person. Read SEC document |
| May 23, 2025 Filed May 21, 2026 21:16 UTC |
Gleason Shane ThomasChief Commercial Officer
|
SaleCommon Stock | 2,482 | $2.51 | $6,229.82 |
DisclosureSEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 9 Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,092,119 F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person. Read SEC document |
| February 25, 2025 Filed May 21, 2026 21:16 UTC |
Gleason Shane ThomasChief Commercial Officer
|
SaleCommon Stock | 10,000 | $3.65 | $36,500.00 |
DisclosureSEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 8 Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,094,601 F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person. Read SEC document |
| February 04, 2025 Filed May 21, 2026 21:16 UTC |
Gleason Shane ThomasChief Commercial Officer
|
SaleCommon Stock | 5,132 | $2.46 | $12,624.72 |
DisclosureSEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 7 Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,104,601 F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person. Read SEC document |
| February 03, 2025 Filed May 21, 2026 21:16 UTC |
Gleason Shane ThomasChief Commercial Officer
|
SaleCommon Stock | 7,073 | $2.51 | $17,753.23 |
DisclosureSEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 6 Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,109,733 F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person. Read SEC document |
| January 31, 2025 Filed May 21, 2026 21:16 UTC |
Gleason Shane ThomasChief Commercial Officer
|
SaleCommon Stock | 9,923 | $2.55 | $25,303.65 |
DisclosureSEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 5 Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,116,806 F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person. Read SEC document |
| January 30, 2025 Filed May 21, 2026 21:16 UTC |
Gleason Shane ThomasChief Commercial Officer
|
SaleCommon Stock | 2,454 | $2.51 | $6,159.54 |
DisclosureSEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 4 Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,126,729 F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person. Read SEC document |
| January 29, 2025 Filed May 21, 2026 21:16 UTC |
Gleason Shane ThomasChief Commercial Officer
|
SaleCommon Stock | 3,660 | $2.46 | $9,003.60 |
DisclosureSEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 3 Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,129,183 F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person. Read SEC document |
| January 28, 2025 Filed May 21, 2026 21:16 UTC |
Gleason Shane ThomasChief Commercial Officer
|
SaleCommon Stock | 2,476 | $2.61 | $6,462.36 |
DisclosureSEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 2 Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,132,843 F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person. Read SEC document |
| January 27, 2025 Filed May 21, 2026 21:16 UTC |
Gleason Shane ThomasChief Commercial Officer
|
SaleCommon Stock | 3,858 | $2.71 | $10,455.18 |
DisclosureSEC source: 0001493152-26-024864 · ownership.xml · nonDerivative · entry 1 Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,135,319 F1 · shares: The sales reported on this Form 4 represent shares of common stock required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock grants pursuant to an automatic sales instruction letter adopted by the reporting person on November 25, 2024 effecting the sell-to-cover election. These sales do not represent discretionary trades by the reporting person. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC |
ROUBIN GARY SDirector
|
GrantOptions to purchase common stock (right to buy) · Derivative | 14,836 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001493152-25-001729 · ownership.xml · derivative · entry 2 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,743 Underlying: Common Stock · 14,836 shares Expires 2035-01-07 F2 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC |
ROUBIN GARY SDirector
|
GrantCommon Stock | 32,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-001729 · ownership.xml · nonDerivative · entry 1 ROUBIN GARY S · CIK 0001162533 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 534,279 F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 7, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC |
Ward Scott R.Director
|
GrantOptions to purchase common stock (right to buy) · Derivative | 7,418 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001493152-25-001735 · ownership.xml · derivative · entry 2 Ward Scott R. · CIK 0001174531 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,065 Underlying: Common Stock · 7,418 shares Expires 2035-01-07 F2 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC |
Ward Scott R.Director
|
GrantCommon Stock | 16,245 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-001735 · ownership.xml · nonDerivative · entry 1 Ward Scott R. · CIK 0001174531 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,793 F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 07, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 16:30 UTC |
Arnold KathrynDirector
|
GrantOptions to purchase common stock (right to buy) · Derivative | 14,836 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001493152-25-001725 · ownership.xml · derivative · entry 2 Arnold Kathryn · CIK 0001861350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,945 Underlying: Common Stock · 14,836 shares Expires 2035-01-07 F2 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 16:30 UTC |
Arnold KathrynDirector
|
GrantCommon Stock | 32,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-001725 · ownership.xml · nonDerivative · entry 1 Arnold Kathryn · CIK 0001861350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 247,531 F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 07, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC |
Slosman MarvinDirector · CEO and President
|
GrantOptions to purchase common stock (right to buy) · Derivative | 254,985 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001493152-25-001731 · ownership.xml · derivative · entry 2 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 937,796 Underlying: Common Stock · 254,985 shares Expires 2035-01-07 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 07, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC |
Slosman MarvinDirector · CEO and President
|
GrantRestricted Stock Units | 558,417 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-001731 · ownership.xml · nonDerivative · entry 1 Slosman Marvin · CIK 0001796908 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,410,536 F1 · shares: These restricted stock units vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 07, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC |
Tommasoli AndreaChief Operating Officer
|
GrantOptions to purchase common stock (right to buy) · Derivative | 106,218 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001493152-25-001733 · ownership.xml · derivative · entry 2 Tommasoli Andrea · CIK 0001969462 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,917 Underlying: Common Stock · 106,218 shares Expires 2035-01-07 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC |
Tommasoli AndreaChief Operating Officer
|
GrantCommon Stock | 232,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-001733 · ownership.xml · nonDerivative · entry 1 Tommasoli Andrea · CIK 0001969462 · Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 727,694 F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC |
Kester Thomas JDirector
|
GrantOptions to purchase common stock (right to buy) · Derivative | 14,836 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001493152-25-001728 · ownership.xml · derivative · entry 2 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,947 Underlying: Common Stock · 14,836 shares Expires 2035-01-07 F2 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC |
Kester Thomas JDirector
|
GrantCommon Stock | 32,491 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-001728 · ownership.xml · nonDerivative · entry 1 Kester Thomas J · CIK 0001299870 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 359,143 F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 07, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC |
Stuka PaulDirector
|
GrantOptions to purchase common stock (right to buy) · Derivative | 22,254 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001493152-25-001732 · ownership.xml · derivative · entry 3 Stuka Paul · CIK 0001528577 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,129 Underlying: Common Stock · 22,254 shares Expires 2035-01-07 F3 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC |
Stuka PaulDirector
|
GrantCommon Stock | 48,736 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-001732 · ownership.xml · nonDerivative · entry 1 Stuka Paul · CIK 0001528577 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 360,284 F1 · shares: These shares of common stock represent shares of restricted stock that shall vest on January 7, 2026 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC |
Verta PatrickEVP Clinical/Medical Affairs
|
GrantOptions to purchase common stock (right to buy) · Derivative | 37,933 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001493152-25-001734 · ownership.xml · derivative · entry 2 Verta Patrick · CIK 0001586025 · EVP Clinical/Medical Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 117,281 Underlying: Common Stock · 37,933 shares Expires 2035-01-07 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC |
Verta PatrickEVP Clinical/Medical Affairs
|
GrantCommon Stock | 83,072 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-001734 · ownership.xml · nonDerivative · entry 1 Verta Patrick · CIK 0001586025 · EVP Clinical/Medical Affairs 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 311,532 F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC |
Gleason Shane ThomasChief Commercial Officer
|
GrantOptions to purchase common stock (right to buy) · Derivative | 106,218 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001493152-25-001727 · ownership.xml · derivative · entry 2 Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 289,346 Underlying: Common Stock · 106,218 shares Expires 2035-01-07 F2 · derivative.exercise_date: The options vest and become exercisable in three equal installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC |
Gleason Shane ThomasChief Commercial Officer
|
GrantCommon Stock | 232,616 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-001727 · ownership.xml · nonDerivative · entry 1 Gleason Shane Thomas · CIK 0001966214 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 746,981 F1 · shares: These shares of common stock represent shares of restricted stock, which vest and become exercisable in three equal annual installments, with 1/3 vesting on each of January 7, 2026, January 7, 2027 and January 7, 2028, subject to the Reporting Person's continued service. Read SEC document |
| January 07, 2025 Filed Jan 10, 2025 21:30 UTC |
BERMAN MICHAELDirector
|
GrantOptions to purchase common stock (right to buy) · Derivative | 14,836 | $0.00 Strike: $2.71 | $0.00 |
DisclosureSEC source: 0001493152-25-001726 · ownership.xml · derivative · entry 3 BERMAN MICHAEL · CIK 0001186801 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 84,950 Underlying: Common Stock · 14,836 shares Expires 2035-01-07 F3 · derivative.exercise_date: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.